Matthew R. Patterson, President & CEO at Audentes Therapeutics, Inc. (BOLD), sold 15,000 shares at $20.00 ($300K) on 2017-07-13, disclosed to the SEC on 2017-07-14.
Open-market sale of $300k BOLD by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 2,850 | $57K | 19.0% |
| 2 | $20.00 | 12,150 | $243K | 81.0% |
| Total | $20.00 avg | 15,000 | $300K | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |